ANGELALIGN: (Revised) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024

Angelalign's revenue for 2024 increased by 28.2% year-on-year to 0.269 billion dollars, and net profit grew by 46.6% to 10 million dollars, with a gross margin maintained at 62.6%. The total number of cases achieved in invisible orthodontics for the year increased by 46.7% to 359,400 cases, among which the number of overseas market cases surged by 326.4% to 140,700 cases. The Board of Directors has proposed a special final dividend of 0.38 HKD per share.Guided by the "Global Organization + Local Operation" strategy, the company's overseas business has expanded rapidly, covering over 50 countries. Revenue from overseas markets grew by 290.4% to 80.5 million dollars, accounting for 30% of total revenue. Revenue from the China market was 0.188 billion dollars, with the number of invisible orthodontics cases achieved increasing by 3.2% to...Show More

Angelalign's revenue for 2024 increased by 28.2% year-on-year to 0.269 billion dollars, and net profit grew by 46.6% to 10 million dollars, with a gross margin maintained at 62.6%. The total number of cases achieved in invisible orthodontics for the year increased by 46.7% to 359,400 cases, among which the number of overseas market cases surged by 326.4% to 140,700 cases. The Board of Directors has proposed a special final dividend of 0.38 HKD per share.Guided by the "Global Organization + Local Operation" strategy, the company's overseas business has expanded rapidly, covering over 50 countries. Revenue from overseas markets grew by 290.4% to 80.5 million dollars, accounting for 30% of total revenue. Revenue from the China market was 0.188 billion dollars, with the number of invisible orthodontics cases achieved increasing by 3.2% to 218,700 cases, maintaining a leading market position.The company continues to increase its investment in R&D, with annual R&D expenditures of 21.3 million dollars, accounting for 7.9% of revenue. In terms of product innovation, new products such as the updated A6? board and KiD Max were launched, and upgrades were made to the functionalities of classic products. The company has also strengthened digital construction, releasing multiple digital tools and new features in solution design, further enhancing the user experience for doctors and the efficiency of diagnosis and treatment.